Skip to main content
Log in

Senile plaques in temporal lobe epilepsy

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Senile plaques (SP) are one of the characteristic pathological lesions of Alzheimer's disease (AD). They are also seen in the brains of some non-demented individuals as an age-related change. Identification of clinical conditions associated with these “incidental” SP could provide insight into AD pathogenesis. We have examined the presence of SP in lobectomy specimens (n=101) removed in the surgical treatment of temporal lobe epilepsy (TLE). SP were present in 10 specimens from epileptic patients aged 36 to 61 years and the presence of SP correlated positively with patient age. No other significant AD-related pathology was identified and no patients showed any evidence of dementia on neuropsychological testing. When compared with temporal lobe tissue from non-demented, non-epileptic autopsy controls (n=406), the density and distribution of SP was the same. The age-related incidence of SP however, was significantly greater in the epileptics. This suggests that some aspects of TLE has a positive influence on the formation of SP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abe K, St. George-Hyslop PH, Tanzi RE, Kogure K (1991) Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells. Neurosci Lett 125: 169–171

    Google Scholar 

  2. Abe K, Tanzi RE, Kogure K (1991) Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci Lett 125: 172–174

    Google Scholar 

  3. Arriagada PV, Marzloff BA, Bradley TH (1992) Distribution of Alzheimer-type pathologic changes in non-demented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42: 1681–1688

    Google Scholar 

  4. Ben-Ari Y (1985) Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14: 375–403

    Google Scholar 

  5. Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Jorm AF, Longley W, Anthony JC (1990) A case-control study of Alzheimer's disease in Australia. Neurology 40: 1698–1770

    Google Scholar 

  6. Burke WJ, O'Malley KL, Chung HD, Harmon SK, Miller JP, Berg L (1991) Effect of pre-and postmortem variables on specific mRNA levels in human brain. Brain Res Mol Brain Res 11: 37–41

    Google Scholar 

  7. Cai XD, Golde TE, Younkin SG (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259: 514–516

    Google Scholar 

  8. Card JP, Meade RP, Davis LG (1988) Immunocytochemical localization of the precursor protein for β-amyloid in the rat central nervous system. Neuron 1: 835–846

    Google Scholar 

  9. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623–634

    Google Scholar 

  10. Corsellis JAN (1970) The neuropathology of temporal lobe epilepsy. In: Williams D (ed.) Modern trends in neurology. Butterworths, London, pp 254–270

    Google Scholar 

  11. Corsellis JAN, Bruton CJ (1983) Neuropathology of status epilepticus in humans. Adv Neurol 34: 129–139

    Google Scholar 

  12. Davies L, Wolska B, Hilbich C, Multhaup G, Martins R, Simms G, Beyreuther K, Masters CL (1988) A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunohistochemistry compared with conventional neuropathologic techniques. Neurology 38: 1688–1693

    Google Scholar 

  13. Delaere P, Duyckaerts C, Masters C, Beyreuther K, Piette F, Hauw JJ (1990) Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person. Neurosci Lett 116: 87–93

    Google Scholar 

  14. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward P (1990) Cleavage of amyloid β peptide during constitutive processing of its precurson. Science 248: 1122–1124

    Google Scholar 

  15. Estus S, Golde T, Kunishita T, Blades D, Lowery D, Eisen M, Usiak M, Qu X, Tabira T, Greenberg BD, Younkin SG (1992) Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255: 726–728

    Google Scholar 

  16. Glenner GG, Wong CW (1984) Alzheimer disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885–890

    Google Scholar 

  17. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rosser M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704–706

    Google Scholar 

  18. Goedert M (1987) Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease. EMBO J 6: 3627–3632

    Google Scholar 

  19. Golde TE, Estus S, Usiak M, Younkin LH, Younkin SG (1990) Expression of β amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron 4: 253–267

    Google Scholar 

  20. Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajusek DC (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235: 877–880

    Google Scholar 

  21. Greenamyre JT, Young AB (1989) Excitatory amino acids and Alzheimer's disease. Neurobiol Aging; 10: 593–602

    Google Scholar 

  22. Hofman A, Schulte W, Tanja TA, Van Duijn CM, Haaxma R, Lameris AJ, Otten VM, Saan RJ (1989) History of dementia and Parkinson's disease in first degree relatives of patients with Alzheimer's disease. Neurology 39: 1589–1592

    Google Scholar 

  23. Joachim CL, Selkoe DJ (1992) The seminal role of β-amyloid in the pathogenesis of Alzheimer disease. Alzheimer Dis Assoc Disord 6: 7–34

    Google Scholar 

  24. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Müller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 325: 733–736

    Google Scholar 

  25. Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H (1988) Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 311: 530–532

    Google Scholar 

  26. Koh J-Y, Yang LL, Cotman CW (1990) β-Amyloid protein increases the vulnerability of of cultured cortical neurons to excitotoxic damage. Brain Res 533: 315–320

    Google Scholar 

  27. Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS, Ballard DJ (1991) Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 41: 1393–1397

    Google Scholar 

  28. Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA (1991) An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc Natl Acad Sci USA 88: 7274–7251

    Google Scholar 

  29. Mann DMA (1988) The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev 43: 99–136

    Google Scholar 

  30. Mann DMA, Esiri MM (1989) The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 89: 169–179

    Google Scholar 

  31. Mann DMA, Tucker CM, Yates PO (1987) The topographic distribution of senile plaques and neurofibrillary tangles in the brains of non-demented persons of different ages. Neuropathol Appl Neurobiol 13: 123–139

    Google Scholar 

  32. Mann DM, Jones D, South PW, Snowden JS, Neary D (1992) Deposition of amyloid β protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of β protein in neurodegenerative disease. Acta Neuropathol 83: 415–419

    Google Scholar 

  33. Margerison JH, Corsellis JAN (1966) Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 89: 499–530

    Google Scholar 

  34. Mastaglia F, Masters CL, Beyreuther K, Kakulas BA (1988) Deposition of amyloid (A4) protein in the cerebral cortex in Parkinson's disease. Alzheimer Dis Assoc Disord 2: 254

    Google Scholar 

  35. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82: 4245–4249

    Google Scholar 

  36. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12: 376–389

    Google Scholar 

  37. Meldrum BS, Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11: 379–387

    Google Scholar 

  38. Mita S, Schon EA, Herbert J (1989) Widespread expression of amyloid beta-protein precursor gene in rat brain. Am J Pathol 134: 1253–1261

    Google Scholar 

  39. Motte J, Williams RS (1989) Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain. Acta Neuropathol 77: 535–546

    Google Scholar 

  40. Munoz DG, McLachlan RS, Blume WT, Kaufmann J, Girvin JP (1990) Abundant neuritic plaques in the temporal lobes of 2 non-demented patients treated surgically for temporal lobe epilepsy (abstract) Neurology 40: 338

    Google Scholar 

  41. Naruse S, Igarashi S, Kobagashi H, Aoki K, Inuzuka T, Kaneko K, Shimizu T, Iihara K, Kojima T, Miyatake T (1991) Mis-sense mutation Val→Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet 337: 978–979

    Google Scholar 

  42. Norstedt C, Gandy SE, Alafuzoff I, Caoraso GL, Iverfeldt K, Grebb JA, Winblad B, Greengard P (1991) Alzheimer βA4-amyloid precursor protein in human brain: aging-associated increased in holoprotein and in a proteolytic fragment. Proc Natl Acad Sci USA 88: 8910–8914

    Google Scholar 

  43. Oliver C, Holland AJ (1986) Down's syndrome and Alzheimer's disease — A review. Psychol Med 16: 307–322

    Google Scholar 

  44. Price JL, Davis PB, Morris JC, White DL (1991) The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 12: 295–312

    Google Scholar 

  45. Robakis NK, Ramakrishna N, Wolfe G, Wisniewski HM (1987) Molecular cloning and characterization of a cDNA encoding the cerebrovascular and neuritic plaque amyloid peptides. Proc Natl Acad Sci USA 84: 4190–4194

    Google Scholar 

  46. Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL (1989) Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 320: 1446–1451

    Google Scholar 

  47. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487–498

    Google Scholar 

  48. Shalat SL, Seltzer B, Pidcock C, Baker EL (1987) Risk factors for Alzheimer's disease: a case-control study. Neurology 37: 1630–1633

    Google Scholar 

  49. Shivers BD, Hilbich C, Multhaup G, Salbaum M, Beyreuther K, Seeburg PH (1988) Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests role in cell contact. EMBO J 7: 1365–1370

    Google Scholar 

  50. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL (1990) Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248: 492–495

    Google Scholar 

  51. Spargo E, Luthert PJ, Jonata I, Lantos PL (1992) βA4 deposition in the temporal cortex of adult with Down's syndrome. J Neurol Sci 111: 26–32

    Google Scholar 

  52. Sparks DL, Hunsaker JL, Scheff SW, Kryscio RJ, Henson JL, Markesbury WR (1990) Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 11: 601–607

    Google Scholar 

  53. Tamaoka A, Kalaria R, Lieberburg I, Selkoe D (1992) Identification of a stable fragment of the Alzheimer amyloid precursor containing the β-protein in brain microvessels. Proc Natl Acad Sci USA 89: 1345–1349

    Google Scholar 

  54. Tan N, Mastaglia F, Masters CL, Beyreuther K, Kakulas BA (1988) Amyloid (A4) deposition in brain in progressive supranuclear palsy (PSP). Alzheimer Dis Assoc Disord 2: 264

    Google Scholar 

  55. Tanzi RE, Gusella JF, Watkins PC, Bruns GAP, St. George-Hyslop P, van Keuren ML, Patterson D, Pagan S, Kurnit DM, Neve RL (1987) Amyloid β protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer's locus. Science 235: 880–884

    Google Scholar 

  56. Tomlinson BE, Blessed G, Roth M (1968) Observations on the brains of non-demented old people. J Neurol Sci 7: 331–356

    Google Scholar 

  57. Ulrich J (1985) Alzheimer changes in nondemented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type. Ann Neurol 17: 273–277

    Google Scholar 

  58. Van Duijn CM, Hendricks L, Cruts M, Hardy JA, Hofman A, Van Broeckhoven C (1991) Amyloid precursor protein gene mutation in early onset Alzheimer's disease. Lancet 337: 978

    Google Scholar 

  59. Van Duijn CM, Hofman A (1991) Risk factors for Alzheimer's disease: a collaborative re-analysis of case control studies. Int J Epidemiol 20 [Suppl 2]: S1-S73

    Google Scholar 

  60. Wakita H, Tomimoto H, Akiguchi I, Ohnishi K, Nakamura S, Kimura J (1992) Regional accumulation of amyloid β/A4 protein precursor in the gerbil brain following transient cerebral ischemia. Neurosci Lett 146: 135–138

    Google Scholar 

  61. Whalley LJ (1982) The dementia of Down's syndrome and its relevance to aetological studies of Alzheimer's disease. Ann NY Acad Sci 396: 39–53

    Google Scholar 

  62. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Harigaya Y (1988) Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol 77: 113–119

    Google Scholar 

  63. Yamaguchi H, Haga C, Hirai S, Nakazato Y, Kosaka K (1990) Distinctive, rapid and easy labelling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain. Acta Neuropathol 79: 569–572

    Google Scholar 

  64. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250: 279–282

    Google Scholar 

  65. Zimmerman K, Herget T, Salbaum JM, Schubert W, Hilbich C, Cramer M, Masters CL, Multhaup G, Kang J, Lemaire HG, Beyreuther R, Starzinski-Powitz A (1988) Localization of the putative precursor of Alzheimer's disease-specific amyloid at nuclear envelopes of adult human muscle. EMBO J 7: 367–372

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Generously supported by a grant from the Alzheimer Association of Ontario

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mackenzie, I.R.A., Miller, L.A. Senile plaques in temporal lobe epilepsy. Acta Neuropathol 87, 504–510 (1994). https://doi.org/10.1007/BF00294177

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00294177

Key words

Navigation